New Medicines articles & resources on Made-in-China.com

Time to Tap Underestimated Resource of TCM

Oct 18, 2016

East is East and West is West and never the twain shall meet" Rudyard Kipling famously wrote, but a recent high level international conference in Frankfurt, Germany, is determined to prove him wrong, at least with regards healthcare, by ...

Tags: TCM, Medicines

The Human Genome Project Was Completed in 2003

Mar 6, 2014

The Human Genome Project was completed in 2003, mapping out all of the genes of the human genome. When the first draft of results were published many were surprised that we had only 24,000 genes. This seemed like an unremarkable amount ...

Tags: Proteins, New Medicines, Better Wine

Scientists From TSRI Developed a General Approach to Design Drugs From Genome Sequence

Feb 26, 2014

In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of ...

Tags: Identify New Drug Candidates, unparalleled selectivity, cell permeable

Furiex Announced Top-Line Results Indicating The Two Pivotal Phase III Clinical Trials

Feb 14, 2014

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced top-line results indicating the company's two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant irritable ...

Tags: Furiex

Astellas and IBL Concludes Co-Research Agreement

Dec 26, 2013

Astellas and IBL Concludes Co-Research Agreement Regarding Pharmaceutical Applications of Recombinant Human Proteins Made Using transgenic Silkworms Tokyo, December 25, 2013 - Astellas Pharma Inc. ("Astellas") and Immuno-Biological ...

Tags: Health, Medicine

Versant Ventures Has Established an Office in Vancouver This Year

Dec 11, 2013

US-based life sciences venture capital firm Versant Ventures is expanding its operations into Canada in order to invest in early-stage drug discovery programs. The company has established an office in Vancouver this year and created a new ...

Tags: Versant Ventures, Drug Discovery

The US Food and Drug Administration Has Granted Orphan Drug Designation

Dec 4, 2013

The US Food and Drug Administration (FDA) has granted orphan drug designation to Conatus Pharmaceuticals' drug candidate emricasan for the treatment of liver transplant patients with reestablished fibrosis to delay the progression to ...

Tags: Health, Medicine, Drug

TransCelerate Is Launching Three New Global Initiatives to Further Advance Efficiency

Nov 12, 2013

US-based TransCelerate BioPharma is launching three new global initiatives to further advance efficiency in clinical trials and accelerate the development of new medicines: creation of common clinical trial protocol templates, development ...

Tags: TransCelerate, clinical trial, Global Initiative, Cubist Pharmaceuticals

Innocore Signed an Agreement with Allergan to Develop New Drugs for Ophthalmic Diseases

Oct 24, 2013

Netherland-based injectable drug delivery products producer InnoCore Pharmaceuticals has signed an exclusive license and collaboration agreement with Allergan (AGN), to develop new medicines for ophthalmic diseases. The deal will see the ...

Tags: injectable drug, Innocore

ViiV Has Announced The FDA Approval of an Integrase Inhibitor,Tivicay 50mg Tablets

Aug 15, 2013

ViiV Healthcare, HIV company established by GlaxoSmithKline and Pfizer, has announced the FDA approval of an integrase inhibitor, Tivicay (dolutegravir) 50mg tablets, for the treatment of HIV-1. Tivicay is indicated for use in combination ...

Tags: Viiv Healthcare, HIV-1

TPI Has Signed a Multi-Million Dollar Joint Investment Framework Agreement with BioMotiv

Aug 15, 2013

Specialty life-science investment company Torrey Pines Investment (TPI) has signed a multi-million dollar joint investment framework agreement with BioMotiv, a biotech accelerator associated with The Harrington Project for Discovery & ...

Tags: Drug Development, Torrey Pines

Ensemble Has Formed a Partnership with Novartis for Oral, Antagonists and Disease Targets

Aug 9, 2013

Ensemble Therapeutics has entered into two-part research and development collaboration with Novartis for oral, macrocyclic inflammatory cytokine IL-17 antagonists and additional disease targets. The collaboration will leverage Ensemble's ...

Tags: Ensemble Therapeutics, Novartis

Eli Lilly and Company Has Reported 31% Increase in Net Income to $1.21bn

Jul 26, 2013

Eli Lilly and Company has reported 31% increase in net income to $1.21bn, or $1.11 per diluted share, for the second quarter ended on 30 July 2013, compared to $923.6m, or $0.83, for the same period last year. Increase in net income and ...

Tags: Eli Lilly, Medicine

SCHOTT Pharmaceutical Systems Will Be Exhibiting at Interphex Japan

Jul 26, 2013

For the first time, SCHOTT Pharmaceutical Systems will be exhibiting at Interphex Japan as an expert on high-quality pharmaceutical tubing. With around 1,000 exhibitors, Interphex is one of the biggest trade shows worldwide for the ...

Tags: Schott, Interphex Japan

Wuxi Selected Instem for Provantis Portal Remote Study Monitoring Solution

Jul 19, 2013

WuXi AppTec (WuXi), a supplier of R&D services to the pharmaceutical, biotechnology, and medical device industries, has selected Instem, a provider of IT solutions to the global early development healthcare market, for Provantis Portal ...

Tags: Monitoring Solution, Medicine

New Medicines

Related Products